Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 6.25
0.00 (0.00%)
Aug 15, 2025, 5:27 PM GMT+1
Abingdon Health Revenue
Abingdon Health had revenue of 3.09M GBP in the half year ending December 31, 2024, with 178.49% growth. This brings the company's revenue in the last twelve months to 6.82M, up 27.60% year-over-year. In the fiscal year ending June 30, 2024, Abingdon Health had annual revenue of 6.14M with 51.67% growth.
Revenue (ttm)
6.82M
Revenue Growth
+27.60%
P/S Ratio
3.45
Revenue / Employee
60.35K
Employees
84
Market Cap
23.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 6.14M | 2.09M | 51.67% |
| Jun 30, 2023 | 4.05M | 1.21M | 42.68% |
| Jun 30, 2022 | 2.84M | -8.78M | -75.60% |
| Jun 30, 2021 | 11.62M | 6.38M | 121.93% |
| Jun 30, 2020 | 5.24M | 2.96M | 129.88% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Oxford Nanopore Technologies | 183.19M |
Abingdon Health News
- 5 months ago - UK Stock Market News: Abingdon Health, Wood Group, Team Internet - The Armchair Trader
- 7 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 8 months ago - Small Cap Stocks: Hummingbird, LPA Group, Cadence Minerals - The Armchair Trader